Search research articles
Contact Us
Filters
Showing results (21-30 of 427) with videos related to
Page
of 43
Sort By:
Journal of Immunology (Baltimore, Md. : 1950)
|
July 1, 1980
Staphylococcal protein A, a T cell-regulated polyclonal activator of human B cells
P E Lipsky
The Journal of Rheumatology. Supplement
|
January 1, 1992
Immunopathogenesis and treatment of rheumatoid arthritis
P E Lipsky
Arthritis and Rheumatism
|
November 1, 1989
The control of antibody production by immunomodulatory molecules
P E Lipsky
Rheumatology (Oxford, England)
|
January 26, 2000
The impact of pharmaco-economic considerations on the utilization of novel anti-rheumatic therapies
P E Lipsky, A Kavanaugh
Springer Seminars in Immunopathology
|
August 17, 2000
The response of human B lymphocytes to oligodeoxynucleotides
H Liang, P E Lipsky
The Journal of Rheumatology
|
June 1, 1993
Immunosuppression by the disease modifying antirheumatic drug bucillamine: inhibition of human T lymphocyte function by bucillamine and its metabolites
K Hashimoto, P E Lipsky
The Medical Clinics of North America
|
January 1, 1997
Treatment of rheumatoid arthritis
R Jain, P E Lipsky
The Journal of Clinical Investigation
|
March 1, 1977
Inhibition of antigen- and mitogen-induced human lymphocyte proliferation by gold compounds
P E Lipsky, M Ziff
Arthritis and Rheumatism
|
June 1, 1994
Comparative inhibitory effects of bucillamine and D-penicillamine on the function of human B cells and T cells
S Hirohata, P E Lipsky
Journal of Immunology (Baltimore, Md. : 1950)
|
April 15, 1989
T cell regulation of human B cell proliferation and differentiation. Regulatory influences of CD45R+ and CD45R- T4 cell subsets
S Hirohata, P E Lipsky
Page
of 43
Search research articles
Search
Showing results (21-30 of 427) with videos related to
Sort By:
Page
of 43
Journal of Immunology (Baltimore, Md. : 1950)
|
July 1, 1980
Staphylococcal protein A, a T cell-regulated polyclonal activator of human B cells
P E Lipsky
The Journal of Rheumatology. Supplement
|
January 1, 1992
Immunopathogenesis and treatment of rheumatoid arthritis
P E Lipsky
Arthritis and Rheumatism
|
November 1, 1989
The control of antibody production by immunomodulatory molecules
P E Lipsky
Rheumatology (Oxford, England)
|
January 26, 2000
The impact of pharmaco-economic considerations on the utilization of novel anti-rheumatic therapies
P E Lipsky, A Kavanaugh
Springer Seminars in Immunopathology
|
August 17, 2000
The response of human B lymphocytes to oligodeoxynucleotides
H Liang, P E Lipsky
The Journal of Rheumatology
|
June 1, 1993
Immunosuppression by the disease modifying antirheumatic drug bucillamine: inhibition of human T lymphocyte function by bucillamine and its metabolites
K Hashimoto, P E Lipsky
The Medical Clinics of North America
|
January 1, 1997
Treatment of rheumatoid arthritis
R Jain, P E Lipsky
The Journal of Clinical Investigation
|
March 1, 1977
Inhibition of antigen- and mitogen-induced human lymphocyte proliferation by gold compounds
P E Lipsky, M Ziff
Arthritis and Rheumatism
|
June 1, 1994
Comparative inhibitory effects of bucillamine and D-penicillamine on the function of human B cells and T cells
S Hirohata, P E Lipsky
Journal of Immunology (Baltimore, Md. : 1950)
|
April 15, 1989
T cell regulation of human B cell proliferation and differentiation. Regulatory influences of CD45R+ and CD45R- T4 cell subsets
S Hirohata, P E Lipsky
Page
of 43